vimarsana.com

Latest Breaking News On - Alignant neoplasia - Page 1 : vimarsana.com

Why Do Certain Patients With Pancreatic Cancer Skip Surgery?

Weight loss during preoperative chemotherapy was one factor associated with reduced odds of undergoing surgical resection for pancreatic cancer.

Journal of the national comprehensive cancer networkOhio state university wexner medical centerNational comprehensive cancerMalignant pancreatic neoplasmPancreatic cancerAncer of the pancreasBiologic therapyWeight managementAlignant neoplasiaAlignant neoplasmWeight lossPractice management

Many Patients With Advanced MCC Not Receiving Immunotherapy

Despite improved survival rates and guideline recommendations, many eligible patients with metastatic Merkel cell carcinoma are not receiving immunotherapy.

New yorkUnited statesFox chase cancer centerJeffrey farmaShayan cheraghlouDepartment of surgical oncologyNational cancer databaseAmerican college of mohs surgeryDrug administrationGrossman school of medicineAmerican collegeMohs surgerySurgical oncologyBiologic therapySkin cancerAlignant skin neoplasm

Correct Dx of Cancer Treatment Skin Effects Evaluated

The survey included 81 dermatologists and 182 medical oncologists at six US-based academic institutions.

United statesNicoler leboeufPp adam friedmanGeorge washington universityDana farber brigham cancer centerDepartment of dermatology at brighamAmerican academy of dermatologyCutaneous oncologyAmerican academyCommon terminology criteriaAdverse eventsAlignant neoplasiaAlignant neoplasmBiologic therapyWashington dcWashington district of columbia

Do No Harm: What Smoldering Myeloma Teaches Us

Manni Mohyuddin, MD, highlights how he treats smoldering multiple myeloma.

Roberta kyleMultiple myelomaPlasma cell myelomaAlignant neoplasiaAlignant neoplasmSmoldering multiple myelomaMoldering multiple myeloma smmX rayBone densityBone mineral densityBone marrowEdulla osseaCancer riskKidney cancerAdrenal cancerBiologic therapy

MicroRNAs Predict Pancreatic Cancer Risk Years in Advance

Expression levels of several microRNAs in plasma samples can help predict the onset of pancreatic cancer up to 5 years prior to clinical diagnosis.

Vanderbilt universityUnited statesCong wangInternational journal of cancerVanderbilt university medical centerShanghai women men health studySouthern community cohort studyScreening trialShanghai womenHealth studyMultiethnic cohortCounter analysis systemInternational journalMalignant pancreatic neoplasmPancreatic cancerAncer of the pancreas

vimarsana © 2020. All Rights Reserved.